iiinova — where your digital self keeps evolving

Adam Raymakers @araymakers.bsky.social · 19/05/2026

Interested in how climate impact could be incorporated into health technology assessment? We leverage real-world evidence for triple therapy inhalers, estimates of the carbon footprint on inhalers, and bring it together in an HTA framework! #ISPORAnnual

000

Adam Raymakers @araymakers.bsky.social · 01/05/2026

Happy to share that I've joined the Editorial Board of the Journal of Cancer Policy as a Section Editor. Really excited to be part of the journal, work with the editorial board, and engage with authors submitting their research! sciencedirect.com/journal/jour...

010

Adam Raymakers @araymakers.bsky.social · 23/04/2026

It's been a few years but really excited to be back at Canada's Drug Agency Symposium 2026! Off to a great start with a plenary on international approaches to HTA with Suzanne McGurn, Sarah Emond, Natalie M., and Yannis Natsis. #CDAAMC26

000

Adam Raymakers @araymakers.bsky.social · 09/10/2025

Some more @cnn.com coverage of our study, led by @wbfeldman.bsky.social, on greenhouse gas emissions associated with inhaler use in the US.

010

Adam Raymakers @araymakers.bsky.social · 06/10/2025

Really excited to share, and happy have been a part of, this new paper led by @wbfeldman.bsky.social out today in @jama.com! We conducted a comprehensive analysis of greenhouse gas emissions associated with inhaler usage in the US. Read it here: jamanetwork.com/journals/jam...

172

Adam Raymakers @araymakers.bsky.social · 27/06/2025

A little work to make one of the local #Squamish trails a bit more friendly to those riding adaptive mountain bikes.

051

Adam Raymakers @araymakers.bsky.social · 10/06/2025

Great and engaging panel discussion about the future of the Inflation Reduction Act by @benro.me and Chris Cai (both from @portalresearch.org), @dusetzinas.bsky.social (Vanderbilt Health Policy), and Alyson Bancroft (@p4ad.bsky.social)! #ARM25

052

Adam Raymakers @araymakers.bsky.social · 09/06/2025

Presenting some work on spending associated with drugs for ultra-rare diseases at the @academyhealth.bsky.social Annual Research Meeting! #arm25 @portalresearch.org

021

Adam Raymakers @araymakers.bsky.social · 08/06/2025

Chris Cai from @portalresearch.org presenting on private equity acquisitions of health care delivery organizations at the @academyhealth.bsky.social Annual Research Meeting. #arm25

130

Adam Raymakers @araymakers.bsky.social · 07/06/2025

On my way to the Academy Health (@academyhealth.bsky.social) Annual Research Meeting in Minneapolis with @jerryavorn.bsky.social in my ear! #arm2025 @portalresearch.org

012

Adam Raymakers @araymakers.bsky.social · 06/06/2025

Looking forward to attending my first ever Academy Health Annual Research Meeting with fellow @portalresearch.org members @benro.me and Chris Cai! I'll be presenting some work on spending associated with drugs for ultra-rare diseases on Sunday. See you there! #arm2025 @academyhealth.bsky.social

061

Adam Raymakers @araymakers.bsky.social · 06/06/2025

Great talk today by Dr Beate Sander at the annual Vancouver Health Economics Methodology Meeting on economic evidence as a component of public health decision making, with lots of discussion about the societal perspective! #healtheconomics #hta

010

Adam Raymakers @araymakers.bsky.social · 27/05/2025

Happy to have been able to help out with new research led by Ian Liu, with co-authors @asarpatwari.bsky.social and @akesselheim.bsky.social (@portalresearch.org). We looked at trials, labelling changes, and revenues associated with the Best Pharmaceuticals for Children Act.

110

Adam Raymakers @araymakers.bsky.social · 23/04/2025

Excited to get this brand new book by Jerry Avorn from @portalresearch.org in the mail today! Can't wait to give it a read! @harvardmed.bsky.social

021

Adam Raymakers @araymakers.bsky.social · 08/04/2025

Happening now! Dr Aaron Kesselheim (@akesselheim.bsky.social) providing testimony to the House Ways and Means Committee on "Lowering Costs for Patients: The Health of the Biosimilar Market." waysandmeans.house.gov/event/health... cc: @portalresearch.org

031

Adam Raymakers @araymakers.bsky.social · 04/03/2025

Our new paper just out in Health Affairs on the use of an administrative pathway (inter partes review) to challenge patents on brand name biologic products and the impact on revenue. Co-authors: Victor van de Wiele, @akesselheim.bsky.social, and @seansst5.bsky.social Link: t.co/YR4qbl3uGM

021

Adam Raymakers @araymakers.bsky.social · 21/02/2025

Well, an earthquake wasn't on today's bingo card but here we are.

020

Adam Raymakers @araymakers.bsky.social · 31/01/2025

🚨 Just out today (online)! 🚨 Our results show that a common argument against #QALYs (based on the use of subgroup analyses) is not justified with empirical data. With co-authors: @leah-rand.bsky.social , @wbfeldman.bsky.social, & @akesselheim.bsky.social from @portalresearch.org.

1107

Adam Raymakers @araymakers.bsky.social · 29/01/2025

Had an interesting discussion about cost-minimization analysis in the context of HTA yesterday which reminded me of writing this article a few years back! (with co-authors from @lshtm.bsky.social and @uniofgalway.bsky.social). www.sciencedirect.com/science/arti... #healtheconomics

121

Adam Raymakers @araymakers.bsky.social · 20/01/2025

Franke made a mid ride mod (i.e., clawed a hole) in her new trailer. Much better now.

240

Adam Raymakers @araymakers.bsky.social · 08/01/2025

Pre-ordered! Excited to read Jerry's new book! @portalresearch.org

020

Adam Raymakers @araymakers.bsky.social · 21/11/2024

Just realized I haven't posted a single dog photo to @bsky.app! Let me fix that.

040

Adam Raymakers @araymakers.bsky.social · 12/11/2024

Presenting some work on QALY-based cost-effectiveness analyses at #SMDM24 a few weeks back that shows some arguments against the use of QALYs lack empirical justification.

071

Adam Raymakers @araymakers.bsky.social · 06/11/2024

Not a big deal in the grand scheme of things but still a fun little milestone!

000

Adam Raymakers @araymakers.bsky.social · 16/11/2023

Reflecting on a chat I had with colleagues about health spending a few days ago and remembered this quote by Robert Evans & Greg Stoddart (1994). Also remembered that reading these words as a 20 year old undergrad economics student basically knocked my socks off!

020

Adam Raymakers @araymakers.bsky.social · 23/10/2023

Our poster today at #SMDM23 wherein we discuss some of the nuances about selecting potential therapeutic alternatives when negotiating prices of selected drugs under the #IRA. #PORTAL_research #healthecon #exonsky

290